✦ LIBER ✦

Tailored regimen of interferon alpha for HBeAg-positive chronic hepatitis B: a prospective controlled study

✍ Scribed by K. Luo; Q. Mao; P. Karayiannis; D. Liu; Z. Liu; Y. Zhou; X. Feng; Y. Zhu; Y. Guo; R. Jiang; F. Zhou; J. Peng; J. Hou

Book ID: 108886150
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 101 KB
Volume: 15
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2008.00995.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy of thymosin alpha-1

Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study

✍ Hyun Woong Lee; Joung Il Lee; Soon Ho Um; Sang Hoon Ahn; Hye Young Chang; Yong K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

Lamivudine and interferon versus lamivud

Lamivudine and interferon versus lamivudine monotherapy for HBeAg-Positive hepatitis B treatment: A meta-analysis of randomized, controlled trials

✍ Dan Rudin 📂 Article 📅 2007 🏛 Springer Healthcare Communications 🌐 English ⚖ 225 KB

Patterns of viral decline during PEG-int

Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response

✍ Martijn J. ter Borg; Monika van Zonneveld; Stefan Zeuzem; Hakan Senturk; Ulus S. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB 👁 2 views

In chronic hepatitis B, it is difficult to predict an early therapeutic response. We investigated the viral decline during therapy with pegylated interferon alpha-2b (PEG-IFN) with or without lamivudine in 266 HBeAg-positive chronic hepatitis B patients. In patients treated with PEG-IFN and lamivudi

A prospective assessment of an ‘a la car

A prospective assessment of an ‘a la carte’ regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers

✍ C. D'Arondel; M. Munteanu; J. Moussalli; V. Thibault; S. Naveau; A. Simon; D. Me 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Daily dose of interferon alpha-2b and ri

Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study

✍ GianPiero Benetti; Mauro Borzio; Giuliano Ramella; Giorgio Bellati; Silvia Fargi 📂 Article 📅 2006 🏛 Springer Milan 🌐 English ⚖ 98 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia

✍ K. Meijer; E. B. Haagsma; J. Van Der Meer; for the CHARIBDIS Study Group 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB